The FDA has extended the deadline for manufacturers, repackagers, and other distributors to place a drug product identifier at the individual package level for each product introduced into interstate commerce.
Beginning November 27, 2017, manufacturers are required to “affix or imprint a product identifier to each package and homogenous case of product intended to be